Archives - October 12, 2020

	Kerala Govt starts welcoming tourists from today, strict COVID guidelines issued It was decided that all the domestic tourists will have to register on Covid jagratha portal and will have to follow the protocols. Beaches will ... Oct 12
	New festive guidelines issued by Delhi Govt The DDMA order said fairs, 'melas', food-stalls (inside and outside the event venues), 'jhoolas, rallies, exhibitions and processions will not be permitted during festivals ... Oct 12
	Bihar Govt : save polling personnel from COVID-19 during upcoming election At the polling stations there will be an arrangement of thermal scanner, hand sanitizer and hand gloves for electorates... Oct 12
	Dr Harsh Vardhan said, Govt. thinking of using more COVID-19 vaccine to cater the huge population Health Minister said, adequate safety and efficacy data is required for emergency use authorization vaccine approval for ensuring patient safety. ... Oct 12
	UP Govt decides to reopen schools from 19th Oct, SOPs issued by Govt Strict COVID guidelines have to be followed by the students and the teachers... Oct 12
	AuraVax Therapeutics collaborates with University of Houston for intranasal COVID-19 vaccine This novel intranasal vaccine technology, stop COVID-19, a respiratory virus, at its point of entry -- the nasal cavity... Oct 12
	CartiHeal receives US FDA approval for its latest medical device The device will provide a promising treatment for millions of patients who suffer from cartilage defects and currently lack good treatment options... Oct 12
	Oxular receives US FDA approval for the treatment of eye cancer Oxular receives rare paediatric disease and orphan-drug designations for retinoblastoma treatment ... Oct 12
	Ayush Ministry : Homoeopathy can do wonders for skin related viral diseases Healing touch of Homoeopathy for viral skin diseases ... Oct 12
	Bristol Myers Squibb to acquire MyoKardia for $13.1 billion in cash The acquisition of MyoKardia further strengthens Bristol Myers Squibb's portfolio, pipeline and scientific capabilities... Oct 12
	Rhizen Pharmaceuticals S.A. and Curon Biopharmaceutical Limited Announce an Exclusive License Agreement to Develop and Commercialize Tenalisib Rhizen and Curon's exclusive license agreement for Tenalisib, a dual PI3K delta & gamma inhibitor in the Greater China region.... Oct 12
	Rhizen Pharmaceuticals S.A. and Curon Biopharmaceutical Limited Announce an Exclusive License Agreement to Develop and Commercialize Tenalisib Rhizen and Curon's exclusive license agreement for Tenalisib, a dual PI3K delta & gamma inhibitor in the Greater China region.... Oct 12
12 Stories found!